Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directl…
An institutional-grade, numbers-driven thesis on HIMS — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 8, 2026, TradersQuant's model rates Hims & Hers Health, Inc. (HIMS) 54/100 with a 12-month base-case forecast of $26.91 — -14.8% versus the current price of $31.59. Hims & Hers Health, Inc. trades at $31.59 in the Healthcare sector, with a market capitalisation of $7.05B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month analyst consensus price target for HIMS is $26.91, implying -14.8% versus the current price. The model's 12-month scenario range runs from $14.35 (bear) to $40.36 (bull), with a base case of $25.27.
On the fundamentals, Hims & Hers Health shows a P/E of -631.8, trailing revenue of $2.35B, revenue growth of +59.0% YoY. This page also tracks HIMS's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
HIMS currently carries a TradersQuant composite score of 54/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "Hold". Our 12-month price target of $26.91 implies -14.8% from $31.59. This is research, not financial advice — always combine it with your own judgement.
The analyst consensus price target for HIMS is $26.91, about -14.8% versus the latest price of $31.59. Consensus is based on 20 analysts.
TradersQuant's 12-month model forecast for HIMS is a base case of $25.27, ranging from $14.35 (bear) to $40.36 (bull), an expected return of -20.0%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for HIMS over the next 12 months is $25.27 in the base case (bear $14.35, bull $40.36), versus today's price of $31.59. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for HIMS — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates HIMS's fair value at $26.91, implying -14.8% of expected upside versus the current price.
Hims & Hers Health does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
